Down 68%, This High-Growth Stock Looks Wildly Undervalued
Riding the pandemic-fueled adoption of its e-signature products, DocuSign (NASDAQ: DOCU) rapidly became one of the tech darlings that saw its share price explode during the peak of COVID-19.
Rising nearly 1,000% after its initial public offering in 2018, DocuSign peaked above $300 per share as its core products became essential for individuals and enterprises alike.
However, over the last six months, DocuSign has seen its shares punished, dropping over 60%, thanks to decelerating billings growth.
Source Fool.com
